logo
11,000 Years of Designer Sheep

11,000 Years of Designer Sheep

New York Times13-02-2025
We've taken dogs and cats into our homes, trained hawks to hunt for us and taught pigeons to deliver our letters.
Our relationship with sheep, though, is more of a symbiosis.
For centuries, we have relied on sheep's wool for clothing and blankets, and they relied on us for shearing. Now, sheep can't molt without human help, though we're using little of their wool. Because consumers today favor softer and less expensive synthetic fibers, an enormous output of raw wool — estimated by researchers at more than 317,000 tons worldwide — goes to waste each year.
This paradox of mutual reliance is at the center of the exhibition, 'Formafantasma — Oltre Terra,' at the Stedelijk Museum Amsterdam, from Feb. 15 through July 13. The show, by the design studio Formafantasma, is billed as examining the 'co-evolution' of sheep and humans across some 11,000 years and contains thoughts about how we might improve the relationship.
Formafantasma, founded by Andrea Trimarchi and Simone Farresin and based in Milan and Rotterdam, the Netherlands, creates products for international companies such as Lexus, Tiffany and Prada, as well as exhibitions for museums and galleries. Its unique design objects have been acquired by arts institutions including the Museum of Modern Art in New York and the Victoria and Albert Museum in London.
'For me they are among the most important designers of their generation,' said Hans Ulrich Obrist, the artistic director of Serpentine, a London-based art institute which hosted a 2022 exhibition by Formafantasma, that focused on a different raw material: wood.
'They have this impressive multidimensionality,' Obrist added. 'They are amazing researchers and they are environmentalists, and at the same time they are creating these extraordinary objects.'
Working with a small team of designers, Trimarchi and Farresin say they begin each project by conducting two or three years of research into the materials they plan to use, a process they call 'investigative design.'
To better understand wool for 'Oltre Terra,' the team began by interviewing experts including farmers, shepherds, biologists and anthropologists, as well as philosophers and activists.
This approach stretched the definition of design to include a process of 'co-creation' between species, said Amanda Pinaith, a Stedelijk curator.
'We as humans have designed this relationship with sheep,' Pinaith said. 'Over hundreds and hundreds of years, tame sheep have developed through human design,' she added, 'so that it would become a wool-producing machine with ears and eyes, instead of an animal.'
Take Shrek, for example, a merino sheep in New Zealand who became a global celebrity in 2005. After escaping his flock, he lived alone for six years until he emerged, weighed down under 60 pounds of fleece. His televised sheering was a national event; he met New Zealand's then-prime minister, Helen Clark; made charity appearances; and was featured in children's books, before he died at age 16 in 2011.
Shrek's reliance on human intervention reflects one small way in which we have, over centuries, 'designed' sheep rather poorly, according to Formafantasma. The Stedelijk exhibition begins with a replica of Shrek, whose story is a useful metaphor for how social design shapes our environment and how we think about nature.
Those relationships are explored in a variety of displays. For example, visitors are invited to sit on a carpet made using 12 types of wool to watch a short video, 'Tactile Afferents,' that explores the nature of physical contact between humans and sheep, created by the artist Joanna Piotrowska.
Photographs of prizewinning Australian merino sheep with rippling fleeces are shown alongside images of the damage that deforestation and overgrazing by the sheep farming industry have caused to Australia's soil and plant life.
The exhibition also explores recent efforts to 'redesign' sheep to produce new breeds that can shed their wool without shearing.
Formafantasma interviewed Tim White, a British sheep breeder who is attempting to crossbreed his sheep with ewes that grow hair instead of wool. In the catalog, White explains that farmers could once pay rent for a full year from wool revenue alone, especially in the early 20th century, when wool was used for army uniforms. Now, however, 'the price of wool doesn't even cover the costs associated with sheering,' he is quoted as saying.
The installation includes information about the crossbreeding efforts by White and others in a large-scale diorama built around an aluminum lattice, on which a range of elements is displayed: videos, taxidermy, archival photographs and objects, like sheep sheering devices from across the ages.
Visitors learn, for example, that the wool we tend to use today is merino, produced in only a few places in the world, primarily Australia and New Zealand. Fleece from most ordinary sheep everywhere else has become waste material, which is usually dumped or burned.
Formafantasma plans to use its accumulated knowledge to find new ways to use excess wool for sustainable design. The studio is already working with an Italian furniture company, Tacchini, to manufacture sofas using surplus wool for the interiors, as a replacement for industrial foam, and with the American textile company, Maharam, to develop a second project, details of which Formafantasma said it could not yet disclose.
Obrist, the Serpentine's art director, said that the strength of Formafantasma's approach was that its research-based method also ends up transforming the ways that real-world products are made.
'At the moment, we have a lot of design is really strong on research but that doesn't produce any objects, and then we have a lot of wonderful design that produces objects, but doesn't have any research,' he said.
'Very few people do both,' Obrist said, 'and I think that's a big achievement.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Hospitals Are Betting On AI To Transform Neurological Diagnosis
Hospitals Are Betting On AI To Transform Neurological Diagnosis

Forbes

time4 hours ago

  • Forbes

Hospitals Are Betting On AI To Transform Neurological Diagnosis

Today, Israel-based Sheba Medical Center — the Middle East's largest medical facility and ranked among the world's top 10 hospitals — announced a joint venture with Revealense — the developer of a neurological-AI engine for analyzing and interpreting human behavior and cognitive state through video — that could bring neurological diagnostics into the home. Buoyed by AI, their idea is presented as both simple and radical all at once: A basic webcam, connected to an AI engine, could help families start assessments for autism or ADHD without ever setting foot in a clinic. Revealense supplies the behavioral-AI technology, Sheba brings the clinical expertise, and together they argue the result could be faster diagnoses, less bias and treatment plans shaped around everyday behavior. ARC (Accelerate, Redesign, Collaborate), Sheba's innovation arm, has already become one of the most active hospital-led incubators of medical technology. This new venture is part of its wider ambition to pull medicine closer to patients — to close the distance and shorten the delays that have long defined access to specialist care. 'The collaboration with Revealense exemplifies Sheba and ARC's unique innovation model — which brings together clinicians on the ground, technological excellence and robust infrastructure to establish entrepreneurial initiatives,' said Avner Halperin, CEO of Sheba Impact at ARC, in the hospital's press release. The Urgency The pressure of autism assessments is real, so the appeal of such technology is easy to understand. Autism evaluations can take months, sometimes years, and the wait can feel endless for families. In the United States, the Centers for Disease Control and Prevention reported that in 2020 about one in 36 children aged 8 was identified with autism, and by 2022 that number had risen to one in 31. While parents are often urged to seek help as early as possible, they usually face year-long delays before receiving answers. ADHD, too, has seen a surge in diagnoses, particularly during the pandemic, when families and schools began paying closer attention to attention disorders and their impact on learning. For parents navigating these waits, a tool that could offer a reliable first step from home is compelling. Earlier assessments mean earlier interventions, which are often the difference between a child thriving or falling behind. 'Beyond dramatically reducing the time needed for diagnosis, the venture also aims to enable earlier detection of syndromes, potentially allowing for initial assessments of autism and other conditions as early as 6 to 12 months of age,' explained Dr. Omer Bar Yosef, Director of the Child Development Center at Sheba Medical Center. Between Potential And Proof But bringing AI into such sensitive territory is not without challenges. Because Autism and ADHD assessments depend on a mix of structured interviews, observation across different environments and careful review of developmental history, assessing both conditions is rarely straightforward. So, without any doubts, turning that into an algorithm is quite complex and critics argue that context matters as much as raw behavior. A toddler's eye movements or gestures, for example, can mean different things depending on culture, language, or environment. There are also several regulatory hurdles to cross. In the United States, for example, the Food and Drug Administration has made clear that AI-driven diagnostic tools will face strict scrutiny, especially those that involve children. In Europe, the AI Act imposes additional requirements for high-risk medical applications. Although what Sheba and Revealense are proposing could reshape access to care, gaining approval across markets is a different game altogether and is often a long process. But both teams say they are well-prepared to go through the rigorous standards designed to protect patients and are confident that their experience in the space sets them apart from the herd. Hospitals As AI Innovators While this technology could potentially transform medical care globally, the bigger story here is about how hospitals themselves are starting to lead this kind of innovation. Sheba, for example, has built a portfolio of clinician-led startups that, according to the hospital, have already produced exits valued at nearly a billion dollars, with profits reinvested into new projects. Its ARC network now also stretches to more than 300 hospitals across 12 countries. Sheba isn't alone in pushing hospitals into the innovation arena. In another example, researchers at Seoul-based Gangnam Severance Hospital and Yonsei University recently published a review on how generative AI might help not only with autism diagnosis but also with personalized treatment plans in real time. They described AI not as an optional add-on but as something that could work alongside clinicians — a partner rather than a product. Increasingly, hospitals are diving into the world of R&D and creating new tools and systems to make medical care even better. That clinician-led model, which blends physician insight with entrepreneurial energy, is catching on very quickly and it could redefine how healthcare systems innovate going forward. As Dov Donin, cofounder and CEO of Revealense, noted, 'It's not just a new technology — it's a paradigm shift that can improve and even save lives, while elevating the entire diagnostics landscape.' But if at-home neurological diagnostics do reach mainstream use in 2026, Sheba and Revealense will be remembered for pioneering a shift in how medicine is delivered. Even if the path is slower, the venture reflects how hospitals are beginning to see AI not as an external product to purchase, but as an internal capability to shape. For families waiting months for answers, that shift holds real promise. For families waiting months for answers, that change holds promise. For healthcare itself, it suggests a new era where hospitals are not just sites of care but laboratories for the future of medicine.

Dr. Lal PathLabs becomes first in India to adopt AI-based module for cancer lymph node metastasis detection
Dr. Lal PathLabs becomes first in India to adopt AI-based module for cancer lymph node metastasis detection

Business Upturn

time10 hours ago

  • Business Upturn

Dr. Lal PathLabs becomes first in India to adopt AI-based module for cancer lymph node metastasis detection

Dr. Lal PathLabs has taken a groundbreaking step in advancing cancer diagnostics in India by becoming the first laboratory in the country to introduce a deep learning-based AI module for the detection of lymph node metastasis, including micrometastasis. This innovation, developed in collaboration with Singapore-based healthtech company Qritive, was recently showcased at USCAP 2025, one of the most prestigious pathology conferences in the world. The accurate detection of cancer spread to lymph nodes is a critical factor in determining the stage and treatment strategy for patients. Missing these signs of cancer progression can allow the disease to advance, increasing the chances of it spreading to distant organs and reducing survival rates. The ability to identify even occult metastases in patients with early-stage cancer has the potential to significantly influence treatment plans and improve outcomes. Traditionally, detecting micrometastases—small clusters of cancer cells hidden in lymph nodes—has been a time-consuming and complex process, often requiring advanced testing. The new AI system, called QiAI Lymph Node Dx, addresses this challenge by using deep learning to analyze digital slides and identify cancer cells with exceptional precision. This integration of AI into diagnostic practice ensures that cancer detection becomes faster, more reliable, and highly accurate. What makes this development especially impactful is its ability to pick up even single cancer cells, which were later validated through immunohistochemistry testing. The AI model has been tested across various cancer types, including breast, colon, stomach, and esophageal cancers, consistently delivering highly accurate results. Breast cancer, which accounts for nearly 28% of cancer cases among women in India, particularly stands to benefit from this breakthrough, highlighting the clinical relevance of the technology. By achieving complete sensitivity and negative predictive value—meaning no metastatic cases went undetected—the AI system has proven to be a robust screening tool. Its tumor-agnostic design allows it to function effectively across different cancer types, making it a versatile solution for oncologists and pathologists alike. As cancer incidence continues to rise in India, the integration of advanced AI-powered diagnostic tools such as QiAI Lymph Node Dx is set to transform the landscape of cancer care. By enabling earlier and more accurate diagnoses, this technology not only improves the efficiency of medical practice but also ensures better treatment decisions, offering renewed hope to patients battling cancer. Ahmedabad Plane Crash

Research says playing Zelda can make you feel happier in life
Research says playing Zelda can make you feel happier in life

Digital Trends

time14 hours ago

  • Digital Trends

Research says playing Zelda can make you feel happier in life

Video games are not merely a form of digital recreation and a means to blow off some steam. Fitness games have proved their worth at boosting mental well-being, while some are finding a purpose in addressing phantom limb pain and helping people with mobility issues in their wrists and hands. As per new research, playing an open-world title like Zelda can significantly increase your happiness. What's the latest on Zelda and science? A team of experts from Imperial College in London, Kyushu Sangyo University, and Georgia State University conducted a randomized test involving more than 500 students. The students were asked to play The Legend of Zelda: Breath of the Wild and watch Studio Ghibli films such as My Neighbor Totoro or Kiki's Delivery Service. At the end of the study, students were presented with a questionnaire that sought to gauge their sense of exploration, calm, mastery, skill, purpose, and meaning in life after exploring the well-received open-world adventure. Based on the students' responses, the researchers came to the conclusion that playing the Zelda series game can help cultivate a sense of happiness by inspiring a spirit of wonder and exploration. Here's a notable excerpt from the research paper: Recommended Videos 'Engaging with these archetypal narratives can prompt a sense of mission: players feel they are contributing to a cause bigger than themselves, even if it is within a fictional world. This 'bigger than self' feeling can be deeply meaningful. Furthermore, many players find calm and meditative moments in the game by simply riding through open fields, quietly gathering resources, or watching sunrises atop tall peaks.' Why does this research matter? Games are often seen as a form of distraction, but after conducting their research, the experts note that they are a means of 'active escapism' that revitalizes energy. That, in turn, helped cope with the feeling of stress, anxiety, and burnout in the students who were a part of the study. Andreas B. Eisingerich, co-author of the research paper and a professor at the Imperial College Business School, remarked that engaging with the world of Zelda can 'actively nurture essential human capacities—exploration, tranquility, purpose-finding, and happiness—and, thus, offer valuable pathways to enhance everyday well-being.' Interestingly, experts claim that watching the nostalgia-evoking Studio Ghibli films and also playing The Legend of Zelda: Breath of the Wild can trigger increased happiness, calm, purpose, and a sensation of discovering meaning in life. You can check out the research paper in JMIR here.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store